| | Author, year | Outcomes | Studies (participants) | Heterogeneity | Relative effect (95% CI) | -value | Quality of Evidence |
| | Guo-zhong Yi, 2014 [25] | RAS | 12 (992) | 0% | RR = 1.29 (1.20, 1.38) | | High | | ECG | 9 (683) | 0% | RR = 1.37 (1.22, 1.54) | | Moderate | | HDL-C | 3 (342) | 0% | MD = 0.29 (0.23, 0.35) | | Low | | LDL-C | 3 (342) | 62% | MD = 1.08 (0.72, 1.44) | | Low | | TG | 3 (342) | 98% | MD = 0.98 (−0.05, 2.02) | | Low | | TC | 3 (342) | 83% | MD = 1.27 (0.63, 1.91) | P=0.0001 | Low | | Shiqi Chen, 2022 [26] | LVEF | 6 (520) | 62% | MD = 6.35 (4.20, 8.50) | | Low | | LVESD | 5 (416) | 98% | MD = −3.48(−5.68, −1.29) | | Low | | NO | 4 (284) | 95% | MD = 12.57 (2.95, 22.19) | | Very Low | | ET-1 | 5 (344) | 99% | MD = −30.93 (−56.59, −5.27) | | Very Low | | ICAM-1 | 3 (170) | 97% | MD = 0.98, (−0.05, 2.02) | | Very Low | | VCAM-1 | 3 (170) | 98% | MD = −41.07 (−94.39, 12.25) | | Very Low | | CRP | 3 (213) | 96% | MD = −1.35 (−3.24, 0.53) | | Very Low | | SOD | 3 (301) | 0% | MD = 19.31 (15.96, 22.66) | | Very Low | | MDA | 3 (301) | 0% | MD = −1.61 (−1.90, −1.33) | | Very Low | | BNP | 3 (192) | 99% | MD = −49.43 (−71.18, −27.68) | | Very Low | | CK-MB | 4 (361) | 96% | MD = −10.08 (−14.01, −6.15) | | Very Low | | Shuo Zhang, 2021 [27] | AF | 9 (1, 349) | 98% | MD = −1.01 (−1.31, −0.71) | | Low | | DAP | 8 (1, 259) | 99% | MD = −1.39 (−1.98, −0.80) | | Low | | Clinical Efficiency Rate | 22 (2, 089) | 0% | RR = 1.24(1.19, 1.29) | | Moderate | | ECG | 7 (619) | 18% | RR = 1.31(1.18, 1.46) | | Moderate | | WBV | 2 (238) | 0% | MD = −0.73 (−0.96, −0.50) | | Low | | PV | 3 (343) | 93% | MD = −0.46(−0.65, −0.28) | | Very Low | | FB | 3 (343) | 68% | MD = −0.65 (−0.79, −0.52) | | Very Low | | NO | 3 (286) | 0% | MD = 4.69 (4.24, 5.13) | | Low | | ET-1 | 3 (286) | 0% | MD = −14.18 (−17.74, −10.61) | | Low | | AE | 6 (716) | 0% | RR = 0.65(0.38, 1.10) | | Low | | Xiaochen Yang, 2014 [28] | RAS | 7 (477) | 0% | RR = 1.26 (1.16, 1.38) | | Low | | ECG | 4 (276) | 0% | RR = 1.20 (1.04, 1.38) | | Very Low | | Zhou Fang, 2016 [29] | Clinical Efficiency Rate | 21 (1, 865) | 58% | RR = 1.24 (1.16, 1.33) | | Low | | ECG | 16 (1, 443) | 74% | RR = 1.42 (1.22, 1.66) | | Low | | Huai Guo, 2017 [30] | Clinical Efficiency Rate | 12 (1, 252) | 0% | OR = 3.56 (2.49, 5.10) | | Low | | CRP | 3 (364) | 53% | MD = −0.91 (−1.14, −0.69) | | Very Low | | ECG | 8 (758) | 15% | OR = 2.76 (1.97, 3.87) | | Low | | Jinfeng Liu, 2020 [31] | RAS | 9 (754) | 0% | RR = 1.24 (1.15, 1.33) | | Moderate | | AE | ECG | 6 (476) | 0% | RR = 1.36 (1.21, 1.53) | | Low | | Min Liu, 2016 [32] | Clinical Efficiency Rate (XFZY + CT vs CT) | 5 (378) | 43% | RR = 1.31 (1.18, 1.44) | | Low | | Clinical Efficiency Rate (XFZY vs CT) | 3 (220) | 41% | RR = 1.24 (1.09, 1.41) | | Low | | RAS (XFZY + CT vs CT) | 5 (378) | 50% | RR = 1.28 (1.06, 1.55) | | Very Low | | RAS (XFZY vs CT) | 2 (120) | 55% | RR = 1.41 (1.07, 1.84) | | Very Low | | Yun Liu, 2017 [33] | RAS | 9 (837) | 0% | OR = 2.83 (2.05, 3.92) | | Low | | ECG | 9 (837) | 0% | OR = 2.83 (2.56, 5.77) | | Low | | Yao Meng, 2021 [34] | RAS | 9 (797) | 0% | OR = 3.75 (2.42, 5.80) | | High | | ECG | 4 (411) | 0% | OR = 4.05 (2.21, 7.42) | | Moderate | | Number of angina attacks | 3 (390) | 97% | SMD = −5.64 (−8.10, −3.18) | | Very Low | | LDL-C | 3 (223) | 91% | SMD = −1.55 (−2.62, −0.48) | | Very Low | | TC | 3 (223) | 59% | SMD = −1.03 (−1.49, −0.56) | | Very Low | | Guohua Zheng, 2012 [35] | ECG (XFZY + CT vs CT) | 10 (717) | 0% | RR = 0.31, (0.21, 0.45) | | Low | | ECG (XFZY vs CT) | 2 (171) | 0% | RR = 0.93, (0.48, 1.81) | | Very Low | | RAS (XFZY + CT vs CT) | 8 (632) | 0% | RR = 0.61 (0.49, 0.75) | | Low | | RAS (XFZY vs CT) | 2 (171) | 0% | RR = 0.98 (0.71, 1.36) | | Very Low |
|
|
